Skip to main content

The Uvea

  • Chapter
  • First Online:
Eye Pathology

Abstract

The uveal tract is the highly vascularised middle layer of the eye and consists of the iris, ciliary body and the choroid. It provides several essential functions to the eye, including nutritive supply to almost all intraocular structures, production of aqueous humor, secretion of hyaluronic acid into the vitreous and control of accommodation. It contains scattered lymphocytes between the normal choroidal pigmented melanocytes; it does not contain lymphatic vessels. Congenital abnormalities of the uvea include albinism, colobomas, corectopias, cysts as well as involvement in syndromes, e.g. neurofibromatosis. The uvea can be involved in inflammatory processes of varying degrees of severity, and they can be localised (diffuse or nodular) as well as part of systemic conditions. Trauma to the uveal tract can be either surgical or nonsurgical. Most cases show intraocular haemorrhage and loss or incarceration of intraocular structures. A particular peculiar but sight threatening condition of the uvea is sympathetic uveitis (ophthalmia), which is a severe bilateral granulomatous inflammation of the uveal tract that follows unilateral trauma or surgery. Degenerative conditions of the uvea include muscle atrophy, hyalinisation, cystic formation as well as choroidal vascularisation; the latter playing a major role in the pathogenesis of age-related macular degeneration. The tumours arising in the uvea are numerous and range from hyperplastic proliferations, to benign neoplasms, to malignancies that are rarely metastatic but typically infiltrative, to other malignancies that can be fatal in close to 50 % of patients and finally to metastatic lesions of systemic tumours within the eye.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Russell-Eggitt I. Albinism. Ophthalmol Clin North Am. 2001;14(3):533–46.

    CAS  PubMed  Google Scholar 

  2. King RA, Pietsch J, Fryer JP, et al. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet. 2003;113(6):502–13.

    CAS  PubMed  Google Scholar 

  3. Ragge NK, Subak-Sharpe ID, Collin JR. A practical guide to the management of anophthalmia and microphthalmia. Eye (Lond). 2007;21(10):1290–300.

    CAS  Google Scholar 

  4. Shah SP, Taylor AE, Sowden JC, et al. Anophthalmos, microphthalmos, and Coloboma in the United Kingdom: clinical features, results of investigations, and early management. Ophthalmology. 2012;119(2):362–8.

    PubMed  Google Scholar 

  5. Glaser T, Walton DS, Maas RL. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat Genet. 1992;2(3):232–9.

    CAS  PubMed  Google Scholar 

  6. Davis A, Cowell JK. Mutations in the PAX6 gene in patients with hereditary aniridia. Hum Mol Genet. 1993;2(12):2093–7.

    CAS  PubMed  Google Scholar 

  7. Warburg M, Mikkelsen M, Andersen SR, et al. Aniridia and interstitial deletion of the short arm of chromosome 11. Metab Pediatr Ophthalmol. 1980;4(2):97–102.

    CAS  PubMed  Google Scholar 

  8. Mataftsi A, Islam L, Kelberman D, Sowden JC, Nischal KK. Chromosome abnormalities and the genetics of congenital corneal opacification. Mol Vis. 2011;17:1624–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Nischal KK. A new approach to the classification of neonatal corneal opacities. Curr Opin Ophthalmol. 2012;23(5):344–54.

    PubMed  Google Scholar 

  10. Kreusel KM. Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications. Fam Cancer. 2005;4(1):43–7.

    PubMed  Google Scholar 

  11. Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88(4):348–54.

    CAS  PubMed  Google Scholar 

  12. Capo H, Palmer E, Nicholson DH. Congenital cysts of the iris stroma. Am J Ophthalmol. 1993;116(2):228–32.

    CAS  PubMed  Google Scholar 

  13. Kim BH, Henderson BA. Intraocular choristoma. Semin Ophthalmol. 2005;20(4):223–9.

    PubMed  Google Scholar 

  14. de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–70.

    PubMed  Google Scholar 

  15. Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–9.

    CAS  PubMed  Google Scholar 

  16. Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20(3):183–90.

    PubMed  Google Scholar 

  17. Kacmaz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Behcet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828–36.

    PubMed Central  PubMed  Google Scholar 

  18. Mesquida M, Molins B, Llorenc V, et al. Current and future treatments for Behcet’s uveitis: road to remission. Int Ophthalmol. 2014;34(2):365–81.

    Google Scholar 

  19. Schuler A, Coupland SE, Krause L, Bornfeld N. Malignant and non-malignant uveitis-masquerade syndromes in childhood. Klin Monbl Augenheilkd. 2007;224(6):477–82.

    CAS  PubMed  Google Scholar 

  20. DeBarge LR, Chan CC, Greenberg SC, McLean IW, Yannuzzi LA, Nussenblatt RB. Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. Surv Ophthalmol. 1994;39(1):65–71.

    CAS  PubMed  Google Scholar 

  21. Thanos A, Vavvas D, Young LH, Foster CS. Choroidal neovascular membrane formation and retinochoroidopathy in a patient with systemic langerhans cell histiocytosis: a case report and review of the literature. Case Rep Ophthalmol. 2012;3(1):128–35.

    PubMed Central  PubMed  Google Scholar 

  22. Tsai JH, Galaydh F, Ching SS. Anterior uveitis and iris nodules that are associated with Langerhans cell histiocytosis. Am J Ophthalmol. 2005;140(6): 1143–5.

    PubMed  Google Scholar 

  23. Rao AA, Naheedy JH, Chen JY, Robbins SL, Ramkumar HL. A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol. 2013;2013:975908.

    PubMed Central  PubMed  Google Scholar 

  24. Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmol. 2005;20(3):191–7.

    PubMed  Google Scholar 

  25. Chu XK, Chan CC. Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthal Inflamm Infect. 2013;3(1):49.

    Google Scholar 

  26. Griepentrog GJ, Lucarelli MJ, Albert DM, Nork TM. Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg. 2005;21(4):316–8.

    PubMed  Google Scholar 

  27. Brour J, Desjardins L, Lehoang P, et al. Sympathetic ophthalmia after proton beam irradiation for choroidal melanoma. Ocul Immunol Inflamm. 2012;20(4):273–6.

    PubMed  Google Scholar 

  28. Damato B. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond). 2012;26(9):1157–72.

    CAS  Google Scholar 

  29. Bonaccolto G. Congenital coloboma associated with cystic degeneration of the ciliary body. AMA Arch Ophthalmol. 1957;57(1):18.

    CAS  PubMed  Google Scholar 

  30. Mannino G, Malagola R, Abdolrahimzadeh S, Villani GM, Recupero SM. Ultrasound biomicroscopy of the peripheral retina and the ciliary body in degenerative retinoschisis associated with pars plana cysts. Br J Ophthalmol. 2001;85(8):976–82.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Ambati J. Age-related macular degeneration and the other double helix. The Cogan Lecture. Invest Ophthalmol Vis Sci. 2011;52(5):2165–9.

    PubMed  Google Scholar 

  32. Liu MM, Chan CC, Tuo J. Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics. 2012;6:13.

    PubMed Central  PubMed  Google Scholar 

  33. Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13(6):438–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Ferris 3rd FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–51.

    PubMed  Google Scholar 

  35. Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85–97, viii.

    PubMed  Google Scholar 

  36. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112(10):1784–9.

    PubMed  Google Scholar 

  37. Kivela T, Eskelin S. Transformation of nevus to melanoma. Ophthalmology. 2006;113(5):887–8.e881.

    PubMed  Google Scholar 

  38. Reidy JJ, Apple DJ, Steinmetz RL, et al. Melanocytoma: nomenclature, pathogenesis, natural history and treatment. Surv Ophthalmol. 1985;29(5):319–27.

    CAS  PubMed  Google Scholar 

  39. Esmaili DD, Mukai S, Jakobiec FA, Kim IK, Gragoudas ES. Ocular melanocytoma. Int Ophthalmol Clin. 2009;49(1):165–75.

    PubMed  Google Scholar 

  40. Fineman MS, Eagle Jr RC, Shields JA, Shields CL, De Potter P. Melanocytomalytic glaucoma in eyes with necrotic iris melanocytoma. Ophthalmology. 1998;105(3):492–6.

    CAS  PubMed  Google Scholar 

  41. Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations. Br J Ophthalmol. 2013;97(7):924–8.

    PubMed  Google Scholar 

  42. Apple DJ, Craythorn JM, Reidy JJ, Steinmetz RL, Brady SE, Bohart WA. Malignant transformation of an optic nerve melanocytoma. Can J Ophthalmol. 1984;19(7):320–5.

    CAS  PubMed  Google Scholar 

  43. Barr CC, Zimmerman LE, Curtin VT, Font RL. Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome. Arch Ophthalmol. 1982;100(2):249–55.

    CAS  PubMed  Google Scholar 

  44. Pulido JS, Flotte TJ, Raja H, et al. Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation. Eye (Lond). 2013;27:1058–62.

    CAS  Google Scholar 

  45. Bechrakis NE, Haas G, Blatsios G. Intraocular manifestations of systemic neoplasms. Klin Monbl Augenheilkd. 2011;228(7):586–592.

    Google Scholar 

  46. Chahud F, Young RH, Remulla JF, Khadem JJ, Dryja TP. Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers. Am J Surg Pathol. 2001;25(2):212–8.

    CAS  PubMed  Google Scholar 

  47. Mudhar HS, Scott I, Ul-Hassan A, et al. Bilateral diffuse uveal melanocytic hyperplasia: molecular characterization and novel association with bilateral renal papillary carcinoma. Histopathology. 2012;61(4):751–4.

    PubMed  Google Scholar 

  48. Carbone M, Ferris LK, Baumann F, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.

    CAS  PubMed Central  PubMed  Google Scholar 

  49. Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  50. McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender’s spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978;86(4):557–64.

    CAS  PubMed  Google Scholar 

  51. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114(10):1925–31.

    PubMed  Google Scholar 

  52. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115(10):1778–85.

    PubMed  Google Scholar 

  53. Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE. Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol. 2011;89(2):e155–60.

    PubMed  Google Scholar 

  54. Coupland SE, Vorum H, Mandal N, et al. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci. 2009;51(1):12–20.

    PubMed  Google Scholar 

  55. Coupland SE, Lake SL, Zeschnigk M, Damato B. Molecular pathology of uveal melanoma. Eye (Lond). 2013;27(2):230–42.

    Google Scholar 

  56. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.

    PubMed Central  PubMed  Google Scholar 

  57. Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363(23):2191–9.

    PubMed Central  PubMed  Google Scholar 

  58. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res. 2010;16(24):6083–92.

    CAS  PubMed  Google Scholar 

  59. Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–95.

    PubMed  Google Scholar 

  60. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205–9.

    CAS  PubMed  Google Scholar 

  61. Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596–603.

    PubMed Central  PubMed  Google Scholar 

  62. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410–3.

    CAS  PubMed Central  PubMed  Google Scholar 

  63. Singh AD, Kaiser PK, Sears JE. Choroidal hemangioma. Ophthalmol Clin North Am. 2005;18(1):151–61, ix.

    PubMed  Google Scholar 

  64. Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye (Lond). 2010;24(3):459–67.

    CAS  Google Scholar 

  65. Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013;27(2):208–16.

    CAS  Google Scholar 

  66. Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma. Surv Ophthalmol. 1988;33(1):17–27.

    CAS  PubMed  Google Scholar 

  67. Saavedra E, Singh AD, Sears JE, Ratliff NB. Plexiform pigmented schwannoma of the uvea. Surv Ophthalmol. 2006;51(2):162–8.

    PubMed  Google Scholar 

  68. Lee SH, Hong JS, Choi JH, Chung WS. Choroidal schwannoma. Acta Ophthalmol Scand. 2005;83(6):754–6.

    PubMed  Google Scholar 

  69. Venturini G, Moulin AP, Deprez M, et al. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology. 2012;119(4):857–64.

    PubMed  Google Scholar 

  70. You JY, Finger PT, Iacob C, McCormick SA, Milman T. Intraocular schwannoma. Surv Ophthalmol. 2013;58(1):77–85.

    PubMed  Google Scholar 

  71. Vannas S, Raitta C, Tarkkanen A. Neurilemmoma of the choroid in Recklinghausen’s disease. Acta Ophthalmol Suppl. 1974;123:126–33.

    CAS  PubMed  Google Scholar 

  72. Freedman SF, Elner VM, Donev I, Gunta R, Albert DM. Intraocular neurilemmoma arising from the posterior ciliary nerve in neurofibromatosis. Pathologic findings. Ophthalmology. 1988;95(11):1559–64.

    CAS  PubMed  Google Scholar 

  73. Donovan BF. Neurilemoma of the ciliary body. AMA Arch Ophthalmol. 1956;55(5):672–5.

    CAS  PubMed  Google Scholar 

  74. Kuchle M, Holbach L, Schlotzer-Schrehardt U, Naumann GO. Schwannoma of the ciliary body treated by block excision. Br J Ophthalmol. 1994;78(5):397–400.

    CAS  PubMed Central  PubMed  Google Scholar 

  75. Thaller VT, Perinti A, Perinti A. Benign schwannoma simulating a ciliary body melanoma. Eye (Lond). 1998;12(Pt 1):158–9.

    Google Scholar 

  76. Kim IT, Chang SD. Ciliary body schwannoma. Acta Ophthalmol Scand. 1999;77(4):462–6.

    CAS  PubMed  Google Scholar 

  77. Hufnagel TJ, Sears ML, Shapiro M, Kim JH. Ciliary body neurilemoma recurring after 15 years. Graefes Arch Clin Exp Ophthalmol. 1988;226(5):443–6.

    CAS  PubMed  Google Scholar 

  78. Laverone F. On a case of solitary neurinoma of the iris. Ann Ottalmol Clin Ocul. 1967;93(11):1210–8.

    CAS  PubMed  Google Scholar 

  79. Racz M, Szabo J. Two cases of neurilemmoma of the anterior uvea (author’s transl). Klin Monbl Augenheilkd. 1973;163(5):605–9.

    CAS  PubMed  Google Scholar 

  80. Brewitt H, Huerkamp B, Richter K. Choroid neurilemmoma. Considerations for clinical differential diagnostics. Klin Monbl Augenheilkd. 1976;169(6):750–4.

    CAS  PubMed  Google Scholar 

  81. Xian J, Xu X, Wang Z, et al. MR imaging findings of the uveal schwannoma. AJNR Am J Neuroradiol. 2009;30(4):769–73.

    CAS  PubMed  Google Scholar 

  82. Matsuo T, Notohara K. Choroidal schwannoma: immunohistochemical and electron-microscopic study. Ophthalmologica. 2000;214(2):156–60.

    CAS  PubMed  Google Scholar 

  83. Turell ME, Hayden BC, McMahon JT, Schoenfield LR, Singh AD. Uveal schwannoma surgery. Ophthalmology. 2009;116(1):163, e166.

    PubMed  Google Scholar 

  84. Cho YJ, Won JB, Byeon SH, et al. A choroidal schwannoma confirmed by surgical excision. Korean J Ophthalmol. 2009;23(1):49–52.

    PubMed Central  PubMed  Google Scholar 

  85. Packard RB, Harry J. Choroidal neurilemmoma–an unusual clinical misdiagnosis. Br J Ophthalmol. 1981;65(3):189–91.

    CAS  PubMed Central  PubMed  Google Scholar 

  86. Shields JA, Font RL, Eagle Jr RC, Shields CL, Gass JD. Melanotic schwannoma of the choroid. Immunohistochemistry and electron microscopic observations. Ophthalmology. 1994;101(5):843–9.

    CAS  PubMed  Google Scholar 

  87. Shields JA, Sanborn GE, Kurz GH, Augsburger JJ. Benign peripheral nerve tumor of the choroid: a clinicopathologic correlation and review of the literature. Ophthalmology. 1981;88(12):1322–9.

    CAS  PubMed  Google Scholar 

  88. Huang Y, Wei W. Choroidal schwannoma presenting as nonpigmented intraocular mass. J Clin Oncol. 2012;30(31):e315–7.

    PubMed  Google Scholar 

  89. Vautrin R, Mertens P, Streichenberger N, Ceruse P, Truy E. Oto-neuro-surgical approach and accessibility to the cochlear nuclei. Significance in auditory brain stem implant. Rev Laryngol Otol Rhinol (Bord). 1998;119(3):171–6.

    CAS  Google Scholar 

  90. Shields JA, Hamada A, Shields CL, De Potter P, Eagle Jr RC. Ciliochoroidal nerve sheath tumor simulating a malignant melanoma. Retina. 1997;17(5):459–60.

    CAS  PubMed  Google Scholar 

  91. Goto H, Mori H, Shirato S, Usui M. Ciliary body schwannoma successfully treated by local resection. Jpn J Ophthalmol. 2006;50(6):543–6.

    PubMed  Google Scholar 

  92. Smith PA, Damato BE, Ko MK, Lyness RW. Anterior uveal neurilemmoma–a rare neoplasm simulating malignant melanoma. Br J Ophthalmol. 1987;71(1):34–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Kiratli H, Ustunel S, Balci S, Soylemezoglu F. Ipsilateral ciliary body schwannoma and ciliary body melanoma in a child. J AAPOS. 2010;14(2):175–7.

    PubMed  Google Scholar 

  94. Pineda 2nd R, Urban Jr RC, Bellows AR, Jakobiec FA. Ciliary body neurilemoma. Unusual clinical findings intimating the diagnosis. Ophthalmology. 1995;102(6):918–23.

    PubMed  Google Scholar 

  95. Rosso R, Colombo R, Ricevuti G. Neurilemmoma of the ciliary body: report of a case. Br J Ophthalmol. 1983;67(9):585–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  96. Carracedo A, Alimonti A, Pandolfi PP. PTEN level in tumor suppression: how much is too little? Cancer Res. 2011;71(3):629–33.

    CAS  PubMed Central  PubMed  Google Scholar 

  97. Shields JA, Shields CL, Eagle Jr RC, De Potter P. Observations on seven cases of intraocular leiomyoma. The 1993 Byron Demorest Lecture. Arch Ophthalmol. 1994;112(4):521–8.

    CAS  PubMed  Google Scholar 

  98. Koletsa T, Karayannopoulou G, Dereklis D, Vasileiadis I, Papadimitriou CS, Hytiroglou P. Mesectodermal leiomyoma of the ciliary body: report of a case and review of the literature. Pathol Res Pract. 2009;205(2):125–30.

    PubMed  Google Scholar 

  99. Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of “reactive lymphoid hyperplasia of the uvea”: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology. 2000;107(1):151–8.

    CAS  PubMed  Google Scholar 

  100. Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol. 2002;197(3):333–40.

    PubMed  Google Scholar 

  101. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008;36(6):564–78.

    PubMed  Google Scholar 

  102. Coupland SE, Joussen A, Anastassiou G, Stein H. Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report. Graefes Arch Clin Exp Ophthalmol. 2005;243(5):482–6.

    PubMed  Google Scholar 

  103. Fuller ML, Sweetenham J, Schoenfield L, Singh AD. Uveal lymphoma: a variant of ocular adnexal lymphoma. Leuk Lymphoma. 2008;49(12):2393–7.

    PubMed  Google Scholar 

  104. Mudhar HS, Sethuraman C, Khan MD, Jan SU. Intracular, pan-uveal intravascular large B-cell lymphoma associated with choroidal infarction and choroidal tri-lineage extramedullary haemtopoiesis. Histopathology. 2007;51(2):275–9.

    CAS  PubMed  Google Scholar 

  105. Coutinho AB, Muccioli C, Martins MC, Belfort Jr R, Sant’Anna AE, Burnier Jr MN. Extranodal B-cell lymphoma of the uvea: a case report. Can J Ophthalmol. 2005;40(5):623–6.

    PubMed  Google Scholar 

  106. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242(11):901–13.

    PubMed  Google Scholar 

  107. Jensen OA, Johansen S, Kiss K. Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature. Graefes Arch Clin Exp Ophthalmol. 1994;232(3):148–52.

    CAS  PubMed  Google Scholar 

  108. Lobo A, Larkin G, Clark BJ, Towler HM, Lightman S. Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Experiment Ophthalmol. 2003;31(2):155–8.

    PubMed  Google Scholar 

  109. Sarraf D, Jain A, Dubovy S, Kreiger A, Fong D, Paschal J. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina. 2005;25(1):94–8.

    PubMed  Google Scholar 

  110. Garcia-Alvarez C, Saornil MA, Blanco G, Mendez MC, Lopez-Lara F. Extranodal B-cell uveal lymphoma with extraocular involvement. Can J Ophthalmol. 2009;44(2):213–4.

    PubMed  Google Scholar 

  111. Gaucher D, Bodaghi B, Charlotte F, et al. MALT-type B-cell lymphoma masquerading as scleritis or posterior uveitis. J Fr Ophtalmol. 2005;28(1):31–8.

    CAS  PubMed  Google Scholar 

  112. Ahmed M, Androudi S, Brazitikos P, Paredes I, Foster CS. 360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol. 2004;19(3–4):127–9.

    PubMed  Google Scholar 

  113. Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol. 2013;41(1):19–26.

    PubMed  Google Scholar 

  114. Yahalom C, Cohen Y, Averbukh E, Anteby I, Amir G, Pe’er J. Bilateral iridociliary T-cell lymphoma. Arch Ophthalmol. 2002;120(2):204–7.

    PubMed  Google Scholar 

  115. Yamada K, Hirata A, Kimura A, Tanihara H. A case of primary B-cell type non-Hodgkin lymphoma originating in the iris. Am J Ophthalmol. 2003;136(2):380–2.

    PubMed  Google Scholar 

  116. Jakobiec FA, Sacks E, Kronish JW, Weiss T, Smith M. Multifocal static creamy choroidal infiltrates. An early sign of lymphoid neoplasia. Ophthalmology. 1987;94(4):397–406.

    CAS  PubMed  Google Scholar 

  117. Kase S, Saito W, Saito A, Ohno S. Uveal effusion syndrome caused by choroidal invasion of malignant lymphoma. Jpn J Ophthalmol. 2010;54(1):109–10.

    PubMed  Google Scholar 

  118. Mathai A, Lall A, Jain R, Pathengay A. Systemic non-Hodgkin’s lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol. 2006;34(3):280–2.

    PubMed  Google Scholar 

  119. Grossniklaus HE, Martin DF, Avery R, et al. Uveal lymphoid infiltration. Report of four cases and clinicopathologic review. Ophthalmology. 1998;105(7):1265–73.

    CAS  PubMed  Google Scholar 

  120. Verity DH, Graham EM, Carr R, van der Walt JD, Stanford MR. Hypopyon uveitis and iris nodules in non-Hodgkin’s lymphoma: ocular relapse during systemic remission. Clin Oncol (R Coll Radiol). 2000;12(5):292–4.

    CAS  Google Scholar 

  121. Berthold S, Kottler UB, Frisch L, Radner H, Pfeiffer N. Secondary glaucoma in hyphema, hypopyon, iris prominence and iris hyperemia. Ophthalmologe. 2005;102(3):290–2.

    CAS  PubMed  Google Scholar 

  122. Saga T, Ohno S, Matsuda H, Ogasawara M, Kikuchi K. Ocular involvement by a peripheral T-cell lymphoma. Arch Ophthalmol. 1984;102(3):399–402.

    CAS  PubMed  Google Scholar 

  123. Yoo JH, Kim SY, Jung KB, Lee JJ, Lee SJ. Intraocular involvement of a nasal natural killer T-cell lymphoma: a case report. Korean J Ophthalmol. 2012;26(1):54–7.

    PubMed Central  PubMed  Google Scholar 

  124. Milman T, Petousis V, McCormick SA, Finger PT. Anterior segment tumor aspiration cutter-assisted biopsy: experience with pathology. Am J Ophthalmol. 2011;152(5):776–83, e771.

    PubMed  Google Scholar 

  125. Economou MA, Kopp ED, All-Ericsson C, Seregard S. Mantle cell lymphoma of the iris. Acta Ophthalmol Scand. 2007;85(3):341–3.

    PubMed  Google Scholar 

  126. Ralli M, Goldman JW, Lee E, Pinter-Brown LC, Glasgow BJ, Sarraf D. Intraocular involvement of mycosis fungoides. Arch Ophthalmol. 2009;127(3):343–5.

    PubMed  Google Scholar 

  127. Shimonagano Y, Nakao K, Sakamoto T, Uozumi K, Haraguchi K. Iris involvement in natural killer/T-cell lymphoma. Jpn J Ophthalmol. 2006;50(6):557–8.

    PubMed  Google Scholar 

  128. Goldey SH, Stern GA, Oblon DJ, Mendenhall NP, Smith LJ, Duque RE. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch Ophthalmol. 1989;107(9):1349–53.

    CAS  PubMed  Google Scholar 

  129. Tavallali A, Shields CL, Bianciotto C, Shields JA. Choroidal lymphoma masquerading as anterior ischemic optic neuropathy. Eur J Ophthalmol. 2010;20(5):959–62.

    PubMed  Google Scholar 

  130. Ponzoni M, Ferreri AJ, Guidoboni M, et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res. 2008;14(18):5794–800.

    CAS  PubMed  Google Scholar 

  131. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96(8):586–94.

    PubMed  Google Scholar 

  132. Ferreri AJ, Dolcetti R, Magnino S, Doglioni C, Ponzoni M. Chlamydial infection: the link with ocular adnexal lymphomas. Nat Rev Clin Oncol. 2009;6(11):658–69.

    PubMed  Google Scholar 

  133. Chanudet E, Zhou Y, Bacon CM, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006;209(3):344–51.

    CAS  PubMed  Google Scholar 

  134. Duker JS, Shields JA, Ross M. Intraocular large cell lymphoma presenting as massive thickening of the uveal tract. Retina. 1987;7(1):41–5.

    CAS  PubMed  Google Scholar 

  135. Fredrick DR, Char DH, Ljung BM, Brinton DA. Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Ophthalmol. 1989;107(3):395–7.

    CAS  PubMed  Google Scholar 

  136. Parikh AH, Khan SH, Wright Jr JD, Oh KT. Systemic non-Hodgkin’s lymphoma simulating primary intraocular lymphoma. Am J Ophthalmol. 2005;139(3):573–4.

    PubMed  Google Scholar 

  137. Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its ocular manifestations. Surv Ophthalmol. 1987;31(5):343–51.

    CAS  PubMed  Google Scholar 

  138. Orellana J, Friedman AH. Ocular manifestations of multiple myeloma, Waldenstrom’s macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol. 1981;26(3):157–69.

    CAS  PubMed  Google Scholar 

  139. Honavar SG, Shields JA, Shields CL, Demirci H, Ehya H. Extramedullary plasmacytoma confined to the choroid. Am J Ophthalmol. 2001;131(2):277–8.

    CAS  PubMed  Google Scholar 

  140. Pilon AF, Rhee PS, Messner LV. Bilateral, persistent serous macular detachments with Waldenstrom’s macroglobulinemia. Optom Vis Sci. 2005;82(7):573–8.

    PubMed  Google Scholar 

  141. Ahn ES, Singh AD, Smith SD. Mantle cell lymphoma with uveal metastasis. Leuk Lymphoma. 2010;51(7):1354–5.

    PubMed  Google Scholar 

  142. Leonardy NJ, Rupani M, Dent G, Klintworth GK. Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol. 1990;109(4):436–44.

    CAS  PubMed  Google Scholar 

  143. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control. 2008;19(4):379–90.

    PubMed  Google Scholar 

  144. Buchan J, McKibbin M, Burton T. The prevalence of ocular disease in chronic lymphocytic leukaemia. Eye (Lond). 2003;17(1):27–30.

    CAS  Google Scholar 

  145. Robb RM, Ervin LD, Sallan SE. A pathological study of eye involvement in acute leukemia of childhood. Trans Am Ophthalmol Soc. 1978;76:90–101.

    CAS  PubMed Central  PubMed  Google Scholar 

  146. Kincaid MC, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983;27(4):211–32.

    CAS  PubMed  Google Scholar 

  147. Schachat AP, Markowitz JA, Guyer DR, Burke PJ, Karp JE, Graham ML. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989;107(5):697–700.

    CAS  PubMed  Google Scholar 

  148. Rosenthal AR. Ocular manifestations of leukemia. A review. Ophthalmology. 1983;90(8):899–905.

    CAS  PubMed  Google Scholar 

  149. Riss JM, Kaplanski G, Righini-Chossegros M, Harle JR, Escoffier P, Saracco JB. Bilateral serous detachment of neuroepithelium of the posterior pole disclosing acute leukemia. J Fr Ophtalmol. 1990;13(11–12):563–8.

    CAS  PubMed  Google Scholar 

  150. Stewart MW, Gitter KA, Cohen G. Acute leukemia presenting as a unilateral exudative retinal detachment. Retina. 1989;9(2):110–4.

    CAS  PubMed  Google Scholar 

  151. Tang RA, Vila-Coro AA, Wall S, Frankel LS. Case report. Acute leukemia presenting as a retinal pigment epithelium detachment. Arch Ophthalmol. 1988;106(1):21–2.

    CAS  PubMed  Google Scholar 

  152. Abdallah E, Hajji Z, Mellal Z, Belmekki M, Bencherifa F, Berraho A. Macular serous detachment revealing acute lymphoblastic leukemia. J Fr Ophtalmol. 2005;28(1):39–44.

    CAS  PubMed  Google Scholar 

  153. Thill M, Schwartz R, Fiedler W, Linke S. Bilateral retinal pigment epithelial detachment as the presenting symptom of acute myeloid leukaemia. Eye (Lond). 2006;20(7):851–2.

    CAS  Google Scholar 

  154. Malik R, Shah A, Greaney MJ, Dick AD. Bilateral serous macular detachment as a presenting feature of acute lymphoblastic leukemia. Eur J Ophthalmol. 2005;15(2):284–6.

    CAS  PubMed  Google Scholar 

  155. Fackler TK, Bearelly S, Odom T, Fekrat S, Cooney MJ. Acute lymphoblastic leukemia presenting as bilateral serous macular detachments. Retina. 2006;26(6):710–2.

    PubMed  Google Scholar 

  156. Moulin AP, Bucher M, Pournaras JA, Nguyen C, Ambresin A. Fluorescein and indocyanine green angiography findings in B cell lymphoblastic leukemia mimicking acute central serous chorioretinopathy. Klin Monbl Augenheilkd. 2010;227(4):342–4.

    CAS  PubMed  Google Scholar 

  157. Zimmerman LE, Thoreson HT. Sudden Loss of Vision in Acute Leukemia. A clinicopathologic report of two unusual cases. Surv Ophthalmol. 1964;9:467–73.

    CAS  PubMed  Google Scholar 

  158. Johnston SS, Ware CF. Iris involvement in leukaemia. Br J Ophthalmol. 1973;57(5):320–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  159. Arbuthnot CD, Bradbury M, Darbyshire PJ. Relapsing acute myeloid leukaemia manifesting as uveitis with hypopyon. Br J Haematol. 2007;136(4):520.

    PubMed  Google Scholar 

  160. Abramson DH, Wachtel A, Watson CW, Jereb B, Wollner N. Leukemic hypopyon. J Pediatr Ophthalmol Strabismus. 1981;18(3):42–4.

    CAS  PubMed  Google Scholar 

  161. Buggage RR, Myers-Powell B, McManaway 3rd J, Shen D, Robinson MR, Chan CC. Detection of the Philadelphia chromosome in the iris of a child with acute lymphoblastic leukaemia. Histopathology. 2005;46(3):350–2.

    CAS  PubMed  Google Scholar 

  162. Schachat AP, Jabs DA, Graham ML, Ambinder RF, Green WR, Saral R. Leukemic iris infiltration. J Pediatr Ophthalmol Strabismus. 1988;25(3):135–8.

    CAS  PubMed  Google Scholar 

  163. Martin B. Infiltration of the iris in chronic lymphatic leukaemia. Br J Ophthalmol. 1968;52(10):781–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  164. Blodi FC. The difficult diagnosis of choroidal melanoma. Arch Ophthalmol. 1963;69:253–6.

    CAS  PubMed  Google Scholar 

  165. Brightbill F. An unusual case of central serous retinopathy. Invest Ophthalmol Vis Sci. 1971;10(60):467.

    Google Scholar 

  166. Clayman HM, Flynn JT, Koch K, Israel C. Retinal pigment epithelial abnormalities in leukemic disease. Am J Ophthalmol. 1972;74(3):416–9.

    CAS  PubMed  Google Scholar 

  167. Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet. 2002;3:179–98.

    CAS  PubMed  Google Scholar 

  168. Teitell MA, Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol. 2009;4: 175–98.

    CAS  PubMed  Google Scholar 

  169. Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265–76.

    CAS  PubMed  Google Scholar 

  170. Kreusel KM, Bechrakis N, Wiegel T, Emmerlich T, Foerster MH. Clinical characteristics of choroidal metastasis. Ophthalmologe. 2003;100(8):618–22.

    PubMed  Google Scholar 

  171. Anderson MF, Coupland SE, Bissett D, Atta H, Damato BE. Choroidal metastasis from primary pulmonary leiomyosarcoma. Clin Experiment Ophthalmol. 2011;39(7):705–7.

    PubMed  Google Scholar 

  172. Shields JA, Eagle Jr RC, Shields CL, De Potter P. Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma). Ophthalmology. 1996;103(12):2007–16.

    CAS  PubMed  Google Scholar 

  173. Buettner H. Congenital hypertrophy of the retinal pigment epithelium. Am J Ophthalmol. 1975;79(2): 177–89.

    CAS  PubMed  Google Scholar 

  174. Trichopoulos N, Augsburger JJ, Schneider S. Adenocarcinoma arising from congenital hypertrophy of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 2006;244(1):125–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah E. Coupland MBBS, PhD, FRCPath .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Coupland, S.E., Moulin, A. (2015). The Uvea. In: Heegaard, S., Grossniklaus, H. (eds) Eye Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43382-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43382-9_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43381-2

  • Online ISBN: 978-3-662-43382-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics